DG

David M. Goldenberg

IM Immunomedics: 11 patents #1 of 11Top 10%
IP Ibc Pharmaceuticals: 5 patents #1 of 7Top 15%
📍 Delray Beach, FL: #2 of 78 inventorsTop 3%
🗺 Florida: #27 of 7,100 inventorsTop 1%
Overall (2019): #3,402 of 560,194Top 1%
16
Patents 2019

Issued Patents 2019

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDate
10436788 Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells Hans J. Hansen, Chien-Hsing Chang 2019-10-08
10413539 Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132) Serengulam V. Govindan 2019-09-17
10385139 Murine, chimeric, humanized or human anti-TNF-alpha antibodies Rongxiu Li, Chien-Hsing Chang 2019-08-20
10377829 Isolated nucleic acid encoding an anti-IGF-1R antibody Chien-Hsing Chang, Michele J. Losman 2019-08-13
10322193 Immunoconjugates with an intracellularly-cleavable linkage Serengulam V. Govindan, Sung-Ju Moon 2019-06-18
10322176 Subcutaneous administration of anti-CD74 antibody for systemic lupus erythematosus William A. Wegener 2019-06-18
10308688 T-cell redirecting bispecific antibodies for treatment of disease Chien-Hsing Chang, Edmund A. Rossi, Diane Rossi 2019-06-04
10266605 Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors Serengulam V. Govindan 2019-04-23
10265414 Immunoconjugates with an intracellularly-cleavable linkage Serengulam V. Govindan, Sung-Ju Moon 2019-04-23
10245321 Combination therapy for inducing immune response to disease Chien-Hsing Chang, Edmund A. Rossi, Diane Rossi, Hans J. Hansen 2019-04-02
10239938 T-cell redirecting bispecific antibodies for treatment of disease Chien-Hsing Chang, Edmund A. Rossi, Diane Rossi, Hans J. Hansen 2019-03-26
10206918 Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers Serengulam V. Govindan, Thomas M. Cardillo 2019-02-19
10195175 Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors Thomas M. Cardillo 2019-02-05
10183992 T-cell redirecting bispecific antibodies for treatment of disease Chien-Hsing Chang, Edmund A. Rossi, Diane Rossi 2019-01-22
10179171 RS7 antibodies Serengulam V. Govindan, Zhengxing Qu, Hans J. Hansen 2019-01-15
10174114 Humanized anti-HLA-DR antibodies Hans J. Hansen, Chien-Hsing Chang 2019-01-08